USMJ and KALY Plant Based Protein Meatless CBD Burger For WCVC Partnership Presentation Coming After Market Today

USMJ and KALY Plant Based Protein Meatless CBD Burger For WCVC Partnership Presentation Coming After Market Today

 

Dallas, TX -- June 27, 2019 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Kali-Extracts (aka Kali, Inc.) (USOTC: KALY) (“KALY”) today announced the presentation scheduled to be released online this Thursday, June 27^th, detailing their partnership to introduce a meatless hamburger infused with CBD is coming after market today.  Look for an aftermarket press release with a link to the presentation. 

Plant based protein alternatives to meat are growing in popularity with consumers.  The recently Beyond Meat (NASDAQ: BYND) partnership with Del Taco introducing meatless tacos has brought a groundswell of attention to the plant based protein sector.  USMJ spun its cannabis themed restaurant off last fall to capitalize and expand the initiative in a partnership with West Coast Venture Group, Corp. (WCVC) (“WCVC”) the owner and operator of Illegal Burger operating in cannabis friendly Colorado.  USMJ CEO Steven Rash currently serves as the CEO of the USMJ cannabis themed restaurant spinoff Now, USMJ is partnering with KALY, the owner and operator of a US Patented Cannabis Extraction product to introduce a meatless CBD infused burger.

See WCVC's recent announcment being named as Rising Star of healthy and holistic restuarants:

WCVC - Illegal Burger Named Rising Star in Healthy Holistic Restaurant Trend Amongst Competitors Including Bloomin' Brands

To learn more visit www.USMJ.com and www.GrowUSMJ.com.

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Steven Rash
CEO North American Cannabis Holdings, Inc.
[e-mail]
[phone]